FDG PET in the clinical evaluation of sarcoidosis with bone lesions

A Kobayashi; T Shinozaki; Y Shinjyo; K Kato; N Oriuchi; H Watanabe; K Takagishi

doi:10.1007/BF02988216

FDG PET in the clinical evaluation of sarcoidosis with bone lesions

Ann Nucl Med. 2000 Aug;14(4):311-3. doi: 10.1007/BF02988216.

Authors

A Kobayashi¹, T Shinozaki, Y Shinjyo, K Kato, N Oriuchi, H Watanabe, K Takagishi

Affiliation

¹ Department of Orthopedic Surgery, Gunma University Faculty of Medicine, Japan.

PMID: 11023033
DOI: 10.1007/BF02988216

Abstract

We report a case of sarcoidosis with osseous involvement. Whole-body fluorine-18-fluorodeoxyglucose (FDG) PET scanning demonstrated multiple sites of FDG uptake in the hilar lymph nodes, right ulna, bilateral feet, and subcutaneous tissue of the extremities. FDG PET scanning provides useful information for the detection of sarcoidosis with systemic distribution, even when osseous lesions are included.

Publication types

Case Reports

MeSH terms

Adult
Bone Diseases / diagnostic imaging*
Female
Fluorine Radioisotopes*
Fluorodeoxyglucose F18*
Humans
Radiography
Sarcoidosis / diagnostic imaging*
Tomography, Emission-Computed / methods*

Substances

Fluorine Radioisotopes
Fluorodeoxyglucose F18